![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/4545 | (2006.01) |
A61K 31/4545 | (2013.01) | ||
A61K 31/5025 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/00 | (2006.01) | ||
C07D 237/00 | (2013.01) | ||
C07D 237/00 | (2006.01) | ||
C07D 405/14 | (2013.01) | ||
C07D 405/14 | (2006.01) | ||
A61K 31/5025 | (2013.01) |
(11) | Patento numeris | 3626239 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 18802340.2 |
Europos patento paraiškos padavimo data | 2018-05-17 | |
(97) | Europos patento paraiškos paskelbimo data | 2020-03-25 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2024-07-03 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/CN2018/087246 |
Data | 2018-05-17 |
(87) | Numeris | WO 2018/210296 |
Data | 2018-11-22 |
(30) | Numeris | Data | Šalis |
201710350614 | 2017-05-18 | CN |
(72) |
MA, Ke , CN
CAO, Guoqing , CN
YANG, Changyong , CN
ZHANG, Lianshan , CN
|
(73) |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. ,
No. 7 Kunlunshan Road
Economic and Technological Development Zone, Lianyungang, Jiangsu 222047,
CN
|
(54) | EZH2 INHIBITOR COMBINED WITH BTK INHIBITOR FOR TREATING TUMOR |
EZH2 INHIBITOR COMBINED WITH BTK INHIBITOR FOR TREATING TUMOR |